Open AccessTreatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a
Author(s) -
Rania El-Lababidi,
Mohamad Mooty,
Maria-Fernanda Bonilla,
Nouran Salem
Publication year - 2020
Publication title -
idcases
Language(s) - English
Resource type - Journals
ISSN - 2214-2509
DOI - 10.1016/j.idcr.2020.e00837
Subject(s) - medicine , covid-19 , pneumonia , outbreak , coronavirus , virology , atypical pneumonia , betacoronavirus , intensive care medicine , disease , infectious disease (medical specialty)
The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.